Day One Biopharmaceutical...

8.07
-0.12 (-1.47%)
At close: Mar 28, 2025, 3:59 PM
8.07
-0.06%
After-hours: Mar 28, 2025, 04:20 PM EDT

Day One Biopharmaceuticals Ratios Statement

Year FY24 FY23 FY22 FY21 FY20 FY19
PE Ratio -12.42 -6.17 -10.66 -14.82 -35.93 -98.93
PEG Ratio 0.22 -0.36 -0.14 -0.2 -0.21 n/a
PS Ratio 9.04 n/a n/a n/a n/a n/a
PB Ratio 2.36 3.36 -5.22 -8.19 -26.85 -136.36
P/FCF Ratio -14.78 -7.76 -12.82 -18.46 -107.16 -322.33
P/OCF Ratio -15.19 -7.93 -12.82 -21.51 -107.89 -322.33
OCF/S Ratio -0.6 n/a n/a n/a n/a n/a
Debt / Equity Ratio 0.01 0.00 -0.00 -0.00 -0.01 n/a
Quick Ratio 7.61 12.72 20.94 33.43 22.58 13.53
Current Ratio 7.66 12.72 20.94 33.43 22.58 13.53
Asset Turnover 0.23 n/a n/a n/a n/a n/a
Interest Coverage n/a n/a -30.95 -18.19K -459.4 -7.18
Return on Equity (ROE) -0.19 -0.55 0.49 0.55 0.75 1.38
Return on Assets (ROA) -0.16 -0.5 -0.38 -0.24 -0.89 -0.54
Return on Capital (ROIC) -0.43 -0.59 -0.44 -0.26 -0.32 -0.59
Dividend Yield n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a
Gross Profit Margin 95.98% n/a n/a n/a n/a n/a
Net Profit Margin -72.81% n/a n/a n/a n/a n/a
Pretax Profit Margin -67.36% n/a n/a n/a n/a n/a
Operating Profit Margin -165.65% n/a n/a n/a n/a n/a
FCF Margin -61.21% n/a n/a n/a n/a n/a
EBITDA Margin -165.65% n/a n/a n/a n/a n/a